Syntal Capital Partners’s Allergan plc AGN Stock Holding History

Syntal Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,500	Closed	-$586K	–	295
2019 Q2	$586K	Hold	3,500	–	–	0.13%	145
2019 Q1	$512K	Hold	3,500	–	–	0.23%	69
2018 Q4	$467K	Hold	3,500	–	–	0.29%	46
2018 Q3	$666K	Sell	3,500 -7	-0.2%	-$1.29K	0.23%	73
2018 Q2	$584K	Hold	3,507	–	–	0.22%	76
2018 Q1	$590K	Buy	3,507 +646	+23%	+$108K	0.21%	81
2017 Q4	$468K	Buy	+2,861	New	+$513K	0.14%	104
2017 Q1	–	Sell	-2,790	Closed	-$585K	–	114
2016 Q4	$585K	Buy	+2,790	New	+$578K	0.54%	21
2015 Q3	–	Sell	-1,203	Closed	-$364	–	162
2015 Q2	$364	Buy	1,203 +7	+0.6%	+$2.09K	0.36%	18
2015 Q1	$355K	Buy	1,196 +364	+44%	+$104K	0.44%	20
2014 Q4	$214K	Buy	+832	New	+$208K	0.13%	57

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Syntal Capital Partners's AGN Position: Q3 2019 in Review

Syntal Capital Partners sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 3,500 shares — an estimated $586K sold.

Syntal Capital Partners first reported a position in AGN in Q4 2014 and held it in 11 quarters. The position peaked at $666K in Q3 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

Syntal Capital Partners reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
Syntal Capital Partners sold 3,500 Allergan plc shares in Q3 2019, an estimated $586K.
Syntal Capital Partners first reported a position in Allergan plc in Q4 2014 and held it in 11 quarters.
Syntal Capital Partners's Allergan plc position peaked at $666K in Q3 2018.
921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Syntal Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.